Metabolon's new biomarker technology adds to drug, nutrient testing capabilities
Morrisville, N.C. —
The Morrisville company has unveiled new software technology that can survey biological samples to see if they contain the more than 4,000 known metabolites within in its chemical library. It’s a capability that Metabolon gained through its acquisition of Lipomics Technologies last year. Lipomics now operates as a division within Metabolon.
The new software can be used in an array of life science applications to discover biomarkers and study the effects of drugs or nutrients on metabolism. TrueVision can also yield insight into disease biology, particularly metabolic diseases.
Metabolism in general, and lipid metabolism in particular, are thought to play an important role in the development of cancer, inflammatory and central nervous system disorders. Metabolon says a comprehensive offering makes this technology especially suited for research in these therapeutic areas.
Please Log In to add a comment.
Best of TechWire Insider
- New GSK oncology consortium targets combination therapies
- Fighting hospital infections: A Durham nurse's dream produces the GoGown
- From photos to out-of-this-world art: Raleigh firm's software transforms images
- LabCorp expands gene tests for cancer - but don't confuse these with 23andMe
- ChannelAdvisor: Mobile cuts deeply into PC share of online shopping
- Inside Appia's latest funding deal: Debt beats dilution
- Can Barley's bark win Super Bowl gold for Durham startup?
- Tech guru Mossberg changes gears, praises Republic Wireless
- Survey explodes myth of the poor VC-backed entrepreneur
- Analyze this: SAS steps up education commitment with Teradata deal